SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-008248
Filing Date
2020-05-11
Accepted
2020-05-11 16:27:00
Documents
69
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 475643
2 ex10-1.htm EX-10.1 148832
3 ex10-2.htm EX-10.2 149722
4 ex10-3.htm EX-10.3 145958
5 ex10-4.htm EX-10.4 145917
6 ex10-5.htm EX-10.5 151648
7 ex31-1.htm EX-31.1 18254
8 ex31-2.htm EX-31.2 18298
9 ex32-1.htm EX-32.1 6496
10 ex32-2.htm EX-32.2 6240
  Complete submission text file 0001493152-20-008248.txt   3923658

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE crbp-20200331.xml EX-101.INS 408952
12 XBRL SCHEMA FILE crbp-20200331.xsd EX-101.SCH 54711
13 XBRL CALCULATION FILE crbp-20200331_cal.xml EX-101.CAL 50518
14 XBRL DEFINITION FILE crbp-20200331_def.xml EX-101.DEF 157982
15 XBRL LABEL FILE crbp-20200331_lab.xml EX-101.LAB 344200
16 XBRL PRESENTATION FILE crbp-20200331_pre.xml EX-101.PRE 244497
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 20865226
SIC: 2834 Pharmaceutical Preparations